[Neuropeptides in the treatment of optic nerve atrophy in children].
The study aimed at investigating the therapeutic effect of the cerebrolysin on partial optic nerve atrophy in children. Six hundreds and forty-six children aged from 8 weeks to 18 years have been studied. Cerebrolysin was injected intramuscularly in dose 0,1 ml per 1 kg of body mass daily and retrobulbar in dose 0,3-0,5 ml; an irrigation system was used to treat a posterior segment of the eye. The illness duration was 10-15 days. The positive effect of the drug, in particular with the following optic nerve stimulation, has been shown. Peculiarities of action of cerebrolysin depending on the initial vision acuity and etiology of disease are emphasized.
Guseva
M R
MR
D000293:Adolescent; D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D009479:Neuropeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D009896:Optic Atrophy / Q000188:drug therapy*; D009900:Optic Nerve / Q000187:drug effects*; D016896:Treatment Outcome
D000596:Amino Acids; D009479:Neuropeptides; C006952:cerebrolysin